By Dr Wendy Winnall - PCFA Research Team Men living in outside metropolitan areas in Australia have a higher risk of dying from prostate cancer. There ...

A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...

Benjamin Netanyahu goes public about his prostate cancer diagnosis for the first time ever. Here is what the Israeli PM said ...

Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha-emitting ...

For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing hormone-releasing hormone (LHRH) agonists as ...

ADT intensification may not improve prostate cancer survival. Explore real-world findings and key risk factors. Read more.

Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by ...

Decades after early trials seemed to close the book on vitamin C as a cancer treatment, a member of a group of determined researchers is receiving the therapy himself.

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in Pharmacological Research, show that an innovative drug effectively prevents ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...